The present proposal to develop an interoperable and secure eHealth platform for patients with Parkinson’s Disease based on open standards (HL7, IHE profile, ITU (H.800-H.899), XML, FIWARE platform) the creation of an ecosystem for remote monitoring of patients with chronic diseases in order to provide new and more effective care to European citizens. With such a holistic solution, specialized care centers will be decoupled and the overall cost of health care reduced, while improving the quality of life of patients.

Our solution is in line with the priorities set by the European Commission:

  • Comparative efficacy research: Our platform will produce new evidence of the efficacy or comparative efficacy of various treatments for Parkinson’s disease patients using a variety of data sources and disseminate the results in a form that can be used quickly. from clinical doctors, patients and health organizations.
  • Advanced technologies: widespread use of cutting-edge technologies in device and platform manufacturing
  • Health Automation: Our solution will be a typical example of health automation due to the use of remote monitoring device and the platform used to analyze the data collected and present the results to physicians and patients.
  • Empowering Patients: Presenting to the patient the results of a combination analysis of gait data together with other clinical data, will encourage active involvement of patients and carers in the evaluation of various therapies
  • Big Data: Our platform will seek to function as a Common Data Platform (CDP), in which big data will be recorded, collected and analyzed by a large number of patients with Parkinson’s disease, using specialized algorithms with particular emphasis on the reliability of results. .

Overall, we believe that our innovative solution will set new directions for the development of surveillance platforms for chronic diseases.

As for other similar devices there are currently three commercially available products worldwide (GaitAid, PDGlasses, LaserCane). However, none of these devices are capable of effectively addressing the major issue of device discretion and therefore have not been widely disseminated. Other than the above-mentioned products, other devices (eg pedometers, s / w analysis activities) do not meet the requirements for precision measurement and specialized data analysis. So potential end users are currently facing some unresolved issues that include:

  • The lack of reliable – and scientifically – designed devices to effectively deal with the effects of Parkinson’s disease.
  • The lack of a single, integrated tool or service for monitoring or predicting disease progression and its consequences
  • Limited public access to information on the development of Parkinson’s disease in the European Union.
Skip to content